-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $50

Benzinga·12/17/2025 20:14:47
語音播報
Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $58 to $50.